Medical Writing Authors and Authorship President’s Message

Volume 25, Issue 1 - Authors and Authorship

President’s Message

Dear EMWA Members,

It is my very great pleasure to ‘speak’ to you from the pages of the very first issue of Medical Writing of 2016, with our new printer, Hastings. I am particularly excited that our feature articles are now open-access – a progressive and forward-thinking move for EMWA and its journal. Not only will authors benefit from an expanded audience, but EMWA will also increase its global reach and ability to influence the medical writing industry.

Our Munich spring conference is just around the corner and your Executive Committee (EC) and an army of volunteers have been working hard these past 10 months to put together another stimulating programme.

If we look back on the past 22 months, we see that our spring conference content has flourished from a sound offering of workshops with Symposium Day back in May 2014, into the complex multi-layered programme that we offer you in May 2016. We should all be proud of EMWA’s maturation.

As usual, foundation and advanced workshops, the Freelance Business Forum and the buzz of medical writers networking will underpin the conference. The 4th Symposium Day on ‘Scientific and Medical Communication Today’ will bring us together with cross industry speakers, panellists and regulators for lively debate on our ever-changing professional landscape. Experienced members will enjoy the 2nd Expert Seminar Series, covering topics as diverse as clinical trial disclosure; referencing software; running medical writing groups in India, China and Japan; artificial intelligence and adaptive study design.

Special Interest Groups (SIGs) will provide EMWA’s very own ‘talking shops’ on hot topics that are expected to develop and endure. The Pharma covigilance Special Interest Group (PV SIG) will delve into issues that impact the PV documents that we write, and with the direct involvement of regulators, you can ask the questions that matter to you. As EMWA and AMWA (American Medical Writers Association) publish the open-access resource CORE (Clarity and Openness in Reporting: E3-based) Reference in May 2016, we will launch the Regulatory Public Disclosure SIG (RPD SIG), a natural follow-up to CORE Reference. RPD SIG will focuson public disclosure of clinical regulatory documents, with the expectation that their content and structure will be impacted; that their range will increase; and that public disclosure will create the need for new documents, which the medical writer will support. The SIGs allow EMWA and its members to contribute to important conversations around topics that we know will impact our industry in the coming years.

We will also trial an internship forum, where potential internees new to medical writing and companies seeking interns can network. With something for everyone – from entry-level right through to experienced members – I invite you to join us in lively Munich from 10th to 14th May 2016 for another memorable conference.

 

Best Wishes
Sam Hamilton

Download the full article

Search

Articles

Authors and Authorship
Letter from the Editor
President’s Message
Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)
The sun never sets on transparency
GPP3 – what is it, why is it necessary and what is new?
Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature
Perspective from a leading scientific author: An interview with Professor Ruth Roberts on authors and authoring
Authorship of clinical trial documents
Project management in medical publication writing: A less explored avenue in pharmaceutical companies and clinical research organisations
Never say never! Returning to full-time employment after freelancing
Fifth EMWA freelance business survey
Journal Watch
In the Bookstores
The Webscout
Regulatory Writing: Authorship issues in regulatory documents
English Grammar and Style
Medical Communication
Lingua Franca and Beyond
Gained in Translation
Medical Writing Teaching
Profile: An interview with Phil Leventhal
EMWA’s 2016 Webinar Programme
Out on our own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Clare Chang

Barbara Grossman

Daniela Nakagawa

Joselita T. Salita

Petal Smart

Amy Whereat

Section Editors

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News       

Aurélie Gobet / Paolo Rega

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh / Stephen Gilliver

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Phil Leventhal

Manuscript Writing

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Namrata Upadhyay

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Laura Kehoe

Out on Our Own

Tiziana von Bruchhausen

Pharmacovigilance

Jennifer Morris

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Kimi Uegaki

The Crofter: Sustainable Communications

Jennifer Bell / Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Lay out Designer

Chris Monk